3Ilkova H,Glaser B,Tunc kale A. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment[J].Diabetes Care,1997,(09):1353-1356.doi:10.2337/diacare.20.9.1353.
7Li Y,Liao Z,Yao B. Induction of long-term glycemic controlin newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function[J].Diabetes Care,2004,(11):2957-2602.
1Derosa G,Carbone A,Franzetti I,et al.Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control,β-cell function and insulin resistance in type 2 diabetic patients[J].Diabetes Res Clin Pract,2012,98(1):51-60.
2Kato H,Nagai Y,Ohta A,et al.Effect of sitagliptin on intrahepatic lipid content and body fat in patients w ith type 2 diabetes[J].Diabetes Res Clin Pract,2015,109(1):199-205.
3Mikada A,Narita T,Yokoyama H,et al.Effects of miglitol,sitagliptin,and initial combination therapy w ith both on plasma incretin responses to a mixed meal and visceral fat in overw eight Japanese patients w ith type 2 diabetes.“The M ASTER randomized,controlled trial”[J].Diabetes Res Clin Pract,2014,106(3):538-547.
4Takai M,Ishikawa M,Maeda H,et al.Safety and efficacy of adding sitagliptin to insulin in patients w ith type 2 diabetes:the ASSIST-K study[J].Diabetes Res Clin Pract,2014,103(3):e30-e33.
5Hibi H,Ohori T,Yamada Y.DPP-IV inhibitor may affect spermatogenesis[J].Diabetes Res Clin Pract,2011,93(2):e74-e75.
6Seck TL,Engel SS,Williams-Herman DE,et al.Sitagliptin more effectively achieves a composite endpoint for Hb A1C reduction,lack of hypoglycemia and no body w eight gain compared w ith glipizide[J].Diabetes Res Clin Pract,2011,93(1):e15-e17.
7Hari Kumar KV,Shaikh A,Prusty P.Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes:a randomized,open label study[J].Diabetes Res Clin Pract,2013,100(2):e55-e58.
8Parmar HS,Jain P,Chauhan DS,et al.DPP-IV inhibitory potential of naringin:an in silico,in vitro and in vivo study[J].Diabetes Res Clin Pract,2012,97(1):105-111.
